XML 25 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Notes Payable and Other Noncurrent Liabilities
9 Months Ended
Sep. 30, 2019
Notes Payable and Other Noncurrent Liabilities  
Notes Payable and Other Noncurrent Liabilities

11. Notes Payable and Other Noncurrent Liabilities

We entered into an amended and restated credit agreement dated January 22, 2019 and two related amendments dated January 31, 2019 and dated February 1, 2019, respectively, that together provide a credit facility of $325,000 comprised of a term loan facility of $243,750 and a revolving credit facility of $81,250, both with a five-year maturity date. The term facility is subject to quarterly amortization of principal, commencing with the fiscal quarter ended June 30, 2019, in equal installments of 5% of the principal amount of the term facility per quarter. Both the term loan and revolver have monthly interest payments currently at 30 Day LIBOR plus an applicable margin of 2%. The proceeds of the term loan, together with $6,250 drawn under the revolver and operating cash on hand were used to complete the Acquisition. Concurrent with the amendment of the credit agreement and Acquisition, we repaid our existing term loan of $59,850 and our cash collateral of $61,667 was released. The amended and restated credit agreement contains standard covenants that, among other things, restrict the Company’s ability to incur additional debt or make certain investments, and require the Company to achieve certain financial ratios and maintain certain financial conditions. As of September 30, 2019, the Company is in compliance with its debt covenants. The Company concluded that the amended and restated credit agreement is considered a loan modification. Accordingly, the Company allocated the costs paid to the bank consortium based on the borrowing dollars and has recorded an asset of $596 and a contra liability of $1,639, which are related to our revolver and term loan, respectively, that is being amortized to interest expense over the five-year maturity date. Additionally, the Company expensed $150 of third-party costs in the first quarter related to this loan modification.

Subsequent Event

The Company entered into a further amendment for the credit facility on October 31, 2019. This amendment increased the revolving commitment by $68,750 to $150,000, while reducing the term loan by the same $68,750 to $150,625. Our consolidated balance sheet was adjusted to reflect the classification of amounts owed per the terms of the credit facility. Subsequent to September 30, 2019, the Company elected to repay the $68,750 revolver on November 1,

2019. Additionally, the Company elected to repay the outstanding revolver as of September 30, 2019 of $26,250 in October of 2019.

As of September 30, 

As of December 31, 

    

2019

    

2018

Notes Payable

 

  

 

  

Note payable, quarterly payment of $8,368 starting December 31, 2019; interest at 30-Day LIBOR plus 2.00% (4.10% at September 30, 2019) through January 22, 2024

$

161,392

$

59,905

Revolving line of credit; interest at 30-Day LIBOR plus 2.0% (4.10% at September 30, 2019)

95,000

 

256,392

 

59,905

Less: Current portion

 

45,332

 

36,468

$

211,060

$

23,437

Payments due under the notes payable obligations are as follows as of September 30, 2019:

2019

    

$

20,474

2020

33,144

2021

33,144

2022

33,144

2023

33,144

Thereafter

103,342

Total

$

256,392